$1.97
+0.02 (+1.03%)
GENK News30 articles
AI Stock Divergence in June: Memory and Power Plays Diverge
June saw a clear divide in AI stocks: suppliers with solid orders versus high-multiple spenders. Key players reported strong revenue, while hyperscalers raised debt to fund buildouts.
Energy Sector Decouples from Oil as Diesel Margins and Norway Lockout Shape Divergent Trends
Brent crude plunged 10.86% last week, but the XLE ETF slipped only 0.4%, signaling a decoupling. Refiners gain from tight diesel margins, while oilfield services face headwinds from a Norway lockout and rising U.S. rig counts.
Generate Biomedicines Shares Reclaim IPO Price After Heavy Trading Week
Generate Biomedicines (GENB) surged 13.7% in a week, closing Friday at $16.47—above its $16 IPO price—with heavy volume and a $2.11B market cap, as sector momentum lifts biotech stocks.
FuelCell Energy Soars on Fit Energy Deal, But Contingencies Loom
FuelCell Energy surged 18.3% after a 30-MW deal with Fit Energy, but most of the 380-MW potential remains contingent on future elections and deposits.
Volkswagen Eyes Up to 100,000 Job Cuts and €23 Billion Investment Reduction
Volkswagen (VOW3) reportedly plans up to 100,000 job cuts, four German plant closures, and a €23 billion investment reduction, reflecting severe margin pressures.
Plug Power's Denmark Project Highlights Green Hydrogen Scaling Challenges
Plug Power shares rose 0.4% to $2.62 after completing a 5 MW electrolyzer project in Denmark, which produces less than 4% of its U.S. capacity. The small scale underscores the challenges in hydrogen scaling.
Tencent Rises as WeCom AI Agent Enters Testing, Buyback Continues
Tencent shares rose 3.38% on Wednesday as WeCom began limited testing of the Dayuan AI agent. The company also repurchased 1.183 million shares.
Pfizer Stock Drops as Seagen Cancer Drug Fails Key Trial
Pfizer shares slid on heavy volume after its Seagen-acquired lung cancer drug failed a Phase 3 trial, casting doubt on a key oncology growth driver ahead of Q2 results.
Soy Allergen Omission Triggers Power Plate Meals Frozen Meatloaf Recall
Power Plate Meals LLC recalls 5,795 pounds of frozen meatloaf with garlic mashed potatoes for undeclared soy. Products shipped to MN, ND, SD; no adverse reactions reported.
KLM Flight KL791 Returns to Amsterdam After Emergency Declaration
KLM flight KL791 declared an emergency and returned to Amsterdam Schiphol, delaying a key Europe-Brazil route. The cause remains unconfirmed, but operations resumed the next day.
Plug Power Stock Jumps 7.5% as Tax Credit Sale Boosts Liquidity, Hydrogen Sector Rallies
Plug Power shares jumped 7.55% on Thursday, driven by a $39.2 million tax credit sale and improved gross margins, as the hydrogen sector broadly rallied.
Volkswagen Shares Slide After Ex-Dividend, CEO Blume Warns of Tough Restructuring
Volkswagen preferred shares dropped 4.24% to €80.53 after trading ex-dividend, as CEO Oliver Blume warned of 'critical' years ahead with 50,000 job cuts and €6 billion in annual savings targeted by 2030.
UniQure Holds Gains as FDA Signals Path for Huntington's Gene Therapy Filing
UniQure shares jumped 78.4% after the FDA said Phase I/II data could support an accelerated-approval filing for its Huntington's disease gene therapy AMT-130. A BLA is planned for Q3 2026.
The Agency Expands in Central America with New Belize Office in Placencia
The Agency has opened its first Belize office in Placencia, expanding its Central America network. The move aims to capture rising foreign buyer interest, though past fraud cases remain a warning for investors.
Nebius Shares Leap 8.4% on Eigen AI Acquisition, Nasdaq-100 Inclusion Looms
Nebius shares surged 8.4% to $287.49 after completing the Eigen AI acquisition, as the company gears up for Nasdaq-100 inclusion on June 22, which could attract index-fund demand.
FDA Greenlights uniQure's Accelerated Approval Path for Huntington's Gene Therapy
uniQure shares surged 78% premarket after the FDA agreed to accept three-year Phase I/II data as the basis for an accelerated approval filing for AMT-130 in Huntington's disease, reviving the near-term U.S. path for the potential first disease-modifying treatment.
NewGenIVF Stock Jumps on Settlement to Buy Back Convertible Notes
NewGenIVF shares rose 20% after the company agreed to a $7.38 million settlement to buy back convertible notes and warrants, aiming to reduce dilution risk.
Regentis Biomaterials Shares Retreat After Record Surge on Withdrawal of Share Offering
Regentis Biomaterials shares dropped 27.66% premarket after a 506% surge driven by the withdrawal of a planned share offering, with investors focusing on upcoming surgeon training and funding concerns.
Regentis Shares Surge After Withdrawing U.S. Share Offering
RGNT surged up to 850% after Regentis withdrew its U.S. share offering, easing dilution fears but leaving funding concerns amid a $13.6 million loss and going concern warning.
Michigan Gas Prices Rise Slightly, Lansing Market Shows Divergence
Michigan's average gas price rose to $4.18/gallon Monday, up from $4.15 last week, with Lansing showing split pump prices. State remains above national average.
PepsiCo Shares Steady Near $144 Amid Analyst Divergence Ahead of Q2 Report
PepsiCo shares ended Friday at $144.27, up 0.39%, as analysts split on the stock ahead of the July 9 Q2 earnings report. Recent price targets range from $143 to $178.
Casey's General Stores Surges on Fuel Margins, Pizza Sales, and Buyback Boost
Casey's General Stores stock jumped 15% after beating Q4 earnings with a 66% EPS jump, driven by fuel margins and pizza sales. The company raised its dividend and expanded buybacks to $1 billion.
Regentis Biomaterials Stock: Surgeon Training for GelrinC Knee Implant Set for Q3
Regentis Biomaterials shares fell slightly premarket after announcing European surgeon training for its GelrinC knee implant will start in Q3, a commercial milestone but not yet revenue.
General Mills Bounces 2.95% Amid Market Slide, Yet Risks Remain
General Mills (GIS) jumped 2.95% to $33.15 on Friday as defensive buying emerged during a broad market decline, but the stock remains about 2% below last week's close, with analysts' average target at $31 signaling caution.
Forgent Power Surges 37% Above Follow-On Price as AI Data Center Demand Drives Record Orders
Forgent Power shares surged 37% above its $47 follow-on price, fueled by record bookings and backlog as AI data center demand keeps investor interest high.
CRISPR Therapeutics Surges 12% on Gene-Editing Sector Rally
CRISPR Therapeutics shares surged 12% in New York trading, buoyed by a sector-wide gene-editing rally and Eli Lilly's $1.9 billion deal with Ascidian Therapeutics.
Dollar General Boosts Outlook as Higher-Income Shoppers Seek Value
Dollar General raised its annual profit forecast after Q1 earnings and margins topped estimates, boosted by increased traffic from higher-income shoppers seeking value amid $4+ gas prices.
Meta Stock Soars 4% on AI Business Agent Launch for WhatsApp, Messenger, Instagram
Meta shares jumped 4.2% to $622.80 after launching an AI business agent across its messaging apps, signaling new paid products as 2026 capex rises to $145 billion.
Legend Biotech Surges 42% on Promising Early CAR-T Data
Legend Biotech shares surged 42% after early Phase 1 data showed all six high-dose patients with relapsed B-cell non-Hodgkin lymphoma responded to its in vivo CAR-T therapy, with five achieving complete responses.
Legend Biotech Surges on Promising Early In Vivo CAR-T Data
Legend Biotech shares soared over 35% after early Phase 1 data showed all six high-dose patients with relapsed/refractory B-cell NHL responded to its in vivo CAR-T drug LB2501, with five complete responses and no relapses as of April 1.